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Abstract
Purpose—To investigate differences in ocular blood flow in individuals of African descent (AD) 
and European descent (ED) with open angle glaucoma (OAG).
Patients and Methods—A retrospective data analysis was performed on OAG patients of AD 
and ED who were previously examined for ocular blood flow within the Department of 
Ophthalmology at Indiana University School of Medicine. Data analysis included blood pressure, 
heart rate, visual fields, intraocular pressure, ocular perfusion pressure, and color Doppler imaging 
of retrobulbar vessels. Color Doppler imaging measurements were performed on ophthalmic, 
central retinal, and nasal and temporal short posterior ciliary arteries, with peak systolic (PSV) and 
end diastolic velocities (EDV) as well as the Pourcelot vascular resistive index calculated for each 
vessel. Two-sample t tests of unequal variance were performed with P values <0.05 considered 
statistically significant.
Results—OAG patients of AD had statistically significant lower retrobulbar blood flow values 
than patients of ED including lower ophthalmic artery PSV (P=0.0001), ophthalmic artery EDV 
(P=0.0008), central retinal artery PSV (P=0.01), temporal short posterior ciliary artery PSV 
(P=0.0037), and nasal short posterior ciliary artery PSV (P<0.0001). No significant differences 
were found in terms of intraocular pressure or visual field parameters.
Conclusions—Significantly lower blood flow values were identified in all retrobulbar blood 
vessels in AD compared with ED OAG patients. These findings suggest that the contribution of 
ocular blood flow to the disease process may be different in AD compared with ED OAG patients.
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Glaucoma, a multifactorial optic neuropathy characterized by progressive retinal ganglion 
cell death and visual field loss, is a leading cause of blindness in persons of African descent 
(AD).1–3 Glaucoma affects up to 6 times as many persons of AD as it does those of 
European descent (ED).1,2 In addition to their increased risk of developing glaucoma, 
persons of AD tend to develop open angle glaucoma (OAG) earlier, have higher disease 
severity, and experience glaucoma progression more quickly, resulting in greater loss of 
visual function.4–10 Although differences exist in the development and progression rates of 
OAG between persons of AD and ED, the mechanisms behind this disparity have yet to be 
elucidated.
Multiple studies have addressed factors that may play a role in the development of 
glaucoma. A recent study suggested that there are no significant differences in the aqueous 
humor dynamics between patients of AD and ED.11 Several studies have shown that people 
of AD have significantly thinner corneas, higher intraocular pressure (IOP), larger optic 
discs, greater optic disc area, and deeper maximum cup depth.5,12 Furthermore, increased 
levels of oxygen in the anterior chamber have been found in individuals of AD as compared 
with those of ED possibly leading to increased oxidative stress and damage.13
Despite being a leading cause of impaired vision worldwide, the risk factors for OAG are 
not fully understood. IOP is the only currently treatable risk factor for OAG, although a high 
percentage of individuals with elevated IOP do not develop glaucoma.14 In addition, many 
patients experience glaucoma progression despite meeting target IOP, suggesting other 
contributing factors in OAG disease onset and progression.15,16
Many clinical studies have linked abnormalities in ocular perfusion pressure (OPP) and 
blood flow to glaucomatous optic neuropathy. Blood flow deficiencies of the retinal, 
choroid, and retrobulbar circulations have been reported in patients with OAG.16 In large 
population-based trials, reduced OPP has been linked to the prevalence, incidence, and 
progression of glaucoma.17–21 Systemic and local vascular abnormalities have also been 
linked to OAG including arterial hypertension, nocturnal hypotension, optic disc 
hemorrhage, migraine, and aging of the vasculature. 16,21 Although some research has 
indicated vascular parameters are associated with glaucoma, their exact relationship to 
glaucoma progression remains insufficiently investigated.
In addition to experiencing disparity in OAG, persons of AD tend to have more systemic 
vasculature complications, leading to numerous medical conditions. Persons of AD have 
considerably higher rates of cardiovascular disease (CVD) with early onset and high 
severity, significantly affected by risk factors such as obesity, smoking, and a sedentary 
lifestyle.22 According to the American Heart Association, the death rate per 100,000 persons 
for stroke were 41.7 for white males, 67.1 for black males, 41.1 for white females, and 57.0 
for black females.23 In the African Descent and Glaucoma Evaluation Study, those of AD 
were documented as having a higher percentage of reported diabetes mellitus, higher blood 
pressure, and higher IOP.24 Nagasubramanian and Weale25 studied the vasculature of the 
optic disc between normal and glaucomatous whites, Africans, and Afro-Caribbeans. The 
vessel pattern differed distinctly between the ethnic groups, with white rims showing a 
higher number of smaller vessels as well as capillary crossings.
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Such studies have demonstrated that there could be a relationship between poor vasculature 
and the severity and earlier onset of glaucoma in AD populations. To the best of our 
knowledge, this is the first investigation that directly examines ocular blood flow parameters 
between persons of AD and ED with OAG in an attempt to help explain the mechanisms 
behind the racial disparities in glaucoma.
MATERIALS AND METHODS
A retrospective analysis was performed using prospectively collected data from previously 
examined OAG patients within the Department of Ophthalmology at Indiana University 
School of Medicine. All participants were established OAG patients and had prior visual 
field experience within the clinic where all measurements used in this analysis were 
performed. Data from only 1 qualified eye was used for each measurement. Data from AD 
and ED OAG patients were separated based on self-reported race and analyzed. All patients 
had OAG based on a clinical examination, visual acuity of 20/60 or better, had treatment of 
timolol (only) for 4 weeks while undergoing washout of all other glaucoma treatments to 
ensure treatment uniformity. Standard Automated Perimetry was performed using the 24-2 
program and Swedish Interactive Thresholding Algorithm on the Humphrey Field Analyzer 
(Carl Zeiss Meditec, Dublin, CA). To be included in the study, the clinical diagnosis of 
OAG had to be confirmed in the study eye by a fellowship-trained glaucoma specialist based 
upon criteria representative of glaucomatous optic disc or retinal nerve fiber layer structural 
abnormalities and/or visual field damage consistent with glaucomatous damage.
All participants were free from other ocular disease or trauma, avoided caffeine for 2 hours 
before exams, and had stable blood pressure. All measurements were performed by a single 
operator (B.S.) in the same clinic between the hours of 8:00 AM and 4:00 PM.
IOP was obtained using Goldmann applanation tonometry. Brachial artery systolic and 
diastolic blood pressure and pulse were assessed after a 5-minute rest period using a 
calibrated automated sphygmomanometer at the beginning of each study visit. Mean arterial 
pressure was calculated as 2/3 diastolic blood pressure+1/3 systolic blood pressure. OPPs 
were calculated as 2/3 mean arterial pressure – IOP.
Color Doppler imaging (CDI) of the retrobulbar blood vessels was conducted using Philips 
HDI 5000 SonoCT Ultrasound System with the microvascular small parts clinical option 
(Philips Medical Systems, Bothell, WA) using a 7.5MHz linear probe as described in detail 
previously.26 CDI measurements were taken in the ophthalmic (OA), central retinal (CRA), 
and nasal and temporal (NPCA/TPCA) short posterior ciliary arteries. In each vessel, peak 
systolic (PSV) and end diastolic (EDV) velocities were determined and the Pourcelot 
vascular resistive index (RI) was calculated [RI=(PSV – EDV)/PSV]. These techniques have 
been previously shown to yield reproducible measurements of retrobulbar blood flow 
velocities and peripheral vascular resistance.26
For each subject, all available data were included for all measurements. Two-sample t tests 
of unequal variance were performed, and all available variables for all patients were 
included with P values <0.05 considered as statistically significant.
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RESULTS
Table 1 lists the mean values, SD, P values, and number of patients for visual fields, IOP, 
blood pressure, heart rate, and OPP in each study group. The mean age and sex of the 
subjects were [age: 68.5 (10.2), 52% female for AD and 70.2 (11.4), 58% female for ED]. 
There were no significant differences between AD and ED OAG patients in visual field 
mean deviation or pattern SD. Also, no statistically significant differences were found in 
terms of IOP between groups. Persons of AD had a significantly higher heart rate 
(P=0.0065), systolic blood pressure (P=0.0001), and diastolic blood pressure (P=0.0022) 
than persons of ED. OPP was significantly higher in OAG patients of AD compared with 
ED (P=0.002).
OAG patients of AD had statistically significant lower retrobulbar blood flow values than 
ED patients. Significantly lower retrobulbar blood flow values for OAG patients of AD 
compared with ED were found for the following retrobulbar blood flow parameters: OA 
PSV (P=0.0001), OA EDV (P=0.0008), CRA PSV (P=0.010), NPCA PSV (P< 0.0001), and 
TPCA PSV (P=0.0037). Only 1 CDI variable was worse in ED with a higher NPCA RI 
(P=0.0029), whereas all other CDI variables were not significantly different between groups 
as shown in Table 2.
DISCUSSION
The mechanism behind the differences in OAG incidence, prevalence, and progression 
between AD and ED populations has yet to be elucidated. Glaucoma risk factors continue to 
evolve away from an IOP-only disease to a multifactorial optic neuropathy. Reductions in 
OPP and blood flow have consistently been shown to be involved in the OAG disease 
process, although the differences in their contribution to OAG pathology between persons of 
AD and ED have yet to be defined. Persons of AD are known to have higher incidence of 
hypertension and other systemic vascular diseases. This provides a strong rationale to 
investigate possible differences that may exist between persons of AD and ED in OPP and 
blood flow.
The results of this study show that persons of AD with OAG had significantly higher 
systolic and diastolic blood pressures than their ED counterparts. This is consistent with 
previous studies demonstrating a greater incidence of hypertension in AD populations.5,27,28 
Prior studies have also noted increased prevalence of diabetes along with hypertension in 
persons of AD.5,27,28 In our analysis, OAG patients of AD also demonstrated significantly 
higher heart rates than persons of ED. This may be related to the increased prevalence of 
hypertension and diabetes in this population. An increased heart rate, in addition to 
hypertension and diabetes, is considered a risk factor for CVD.29,30 Results from the Ocular 
Hypertension Treatment Study suggest that a greater occurrence of CVD may be linked to 
the higher incidence of glaucoma in African Americans.31
Some studies attribute the increased prevalence and incidence of OAG in persons of AD to 
elevated IOP. For example, it has been shown that the risk of developing glaucoma increases 
25-fold between an IOP of 17 and 25mm Hg.20 The Barbados Eye Study demonstrated that 
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African Americans examined had much higher IOP levels.32 In the present study, we do not 
believe that the racial differences we observed in ocular blood can be explained by 
differences in IOP because we found no differences in treated IOP between the AD and ED 
groups. It is worth noting that analyses from several population-based studies, including the 
Barbados, Rotterdam, and Baltimore studies revealed that increased IOP may be linked with 
hypertension. 5,27,28,33,34 Hence, the high incidence of hypertension found in the AD 
population may account for some of the reports of higher IOP.5,27,28 Furthermore the racial 
differences in ocular blood flow that we report here were likely not due to differences in the 
severity of glaucoma between the 2 groups. Indeed, we found no differences in the visual 
parameters between people of AD and ED, although the number of available fields for OAG 
patients of AD was less than those available for OAG of ED which is a limitation.
The comparison of retrobulbar blood flow parameters between AD and ED OAG patients 
revealed a uniform reduction in retrobulbar circulation in persons of AD compared with 
their ED counterparts. In our study, OA PSV and EDV, CRA PSV, NPCA PSV, and TPCA 
PSV were significantly lower in persons of AD compared with ED OAG patients. With only 
1 CDI variable was worse in ED (higher NPCA RI), our data indicate a clear trend of lower 
ocular circulation in persons of AD compared with ED despite similar IOP and visual field 
defects. Previous studies have demonstrated reduced blood flow velocities in the retrobulbar 
vessels of glaucoma patients.35–39 Specifically, Martinez and Sanchez40 showed that 
vascular resistance of retrobulbar vessels may predict visual field progression, whereas 
Galassi et al41 demonstrated that constricted retrobulbar flow was associated with visual 
field loss. These findings suggest that the contribution of ocular blood flow to the disease 
process may be different in AD compared with ED OAG patients.
An increase in IOP or reduction in systemic blood pressure has the potential to lower 
retrobulbar blood flow values through a reduction in OPP.42,43 However, the lower blood 
flow values we found in all retrobulbar blood vessels in patients of AD are not explained by 
IOP or systemic blood pressure, as no difference in IOP was found between the groups and 
blood pressure was higher in patients of AD. This is a strong indication that reduced 
localized ocular circulation may contribute to OAG differently in persons of AD compared 
with persons of ED. Reductions in retrobulbar blood flow velocities in persons of AD may 
represent non-IOP and OPP-related localized vascular deficits, faulty vascular regulation, or 
may be a part of an overall systemic vascular disease process apparent in the AD population. 
It is also important to consider that IOP may not be an ideal surrogate of the resistance of 
ocular perfusion. The resistance from ocular vessel may play a more important role in ocular 
perfusion.
Our study has several limitations to acknowledge. These include a lack of prospective 
follow-up and non-availability of optic disc parameters such as cup-disc ratio (C/D ratio), 
corneal thickness, oxygen levels, and genetics. For example, several studies have shown that 
persons of AD have significantly larger C/D ratios than whites.7,31,44–46 C/D ratio, like 
diabetes and hypertension, has been positively linked with IOP.32 Race was self-reported, 
which may also be a limitation of the study. However, self-described race has demonstrated 
a high correlation with more sophisticated measures of racial classification using genetic 
admixture techniques and thus is likely an adequate surrogate measure. 10,47 Our study is 
Siesky et al. Page 5
J Glaucoma. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
also limited by the fact that there was a greater number of patients of ED than AD which 
may affect the comparisons between groups, although all available data for all subjects were 
included for each measure without selection bias. As our data were retrospective and 
deidentified at the time of analysis we also could not perform more advanced statistical 
analysis such as multivariate or multiple linear regressions including all the potential-related 
variables to screen the independent associated factors. It is important to note, however, that 
the direction of the results we obtained suggests that the differences would be in the same 
direction and likely stronger even after adjusting for possible confounds such as blood 
pressure, heart rate, and OPP. Indeed, people of AD had higher blood pressure, heart rate, 
and OPP, yet lower ocular blood flow. This remains a limitation of the current data set 
nonetheless. It is also important to note that our study, while suggestive, is not able to 
establish causality of OAG due to lower ocular blood flow due to its retrospective design.
This study, to the best of our knowledge, is the first to demonstrate directly measured 
differences in ocular blood flow between AD and ED OAG patients. Our study revealed a 
higher incidence of cardiovascular risk factors, which have been linked to glaucoma, such as 
hypertension and increased heart rate, in persons with OAG of AD compared with ED 
patients. Significantly lower blood flow values were identified in all retrobulbar blood 
vessels in persons of AD compared with ED OAG patients despite similar IOP and visual 
field parameters. These findings suggest that the contribution of ocular blood flow to 
glaucoma may be different in AD compared with ED patients. Additional research is needed 
to determine whether the differences in ocular blood flow reported in this study may be 
related to disparities in the rate of glaucoma progression.
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TABLE 1
The Visual Field, Intraocular Pressure, Blood Pressure, Heart Rate, and Ocular Perfusion Pressure Parameters 
are Presented for Each Study Group
AD Mean±SD (n) ED Mean±SD (n) P
MD (dB) −1.94±2.77 (19) −2.17±4.38 (74) 0.78
PSD (dB) 3.02±2.55 (19) 3.23±3.68 (74) 0.77
IOP (mm Hg) 15.99±4.03 (60) 15.50±4.44 (115) 0.46
Systolic BP (mm Hg) 137.45±19.66 (66) 126.59±14.03 (123) 0.0001
Diastolic BP (mm Hg) 83.17±11.53 (66) 77.97±9.57 (123) 0.0022
HR (bpm) 78.68±18.01 (66) 71.92±11.01 (123) 0.0065
Mean OPP (mm Hg) 51.42±8.98 (60) 47.14±7.54 (115) 0.0021
Bold P-values indicate statistical significance.
AD indicates African descent; BP, blood pressure; ED, European descent; HR, heart rate; IOP, intraocular pressure; MD, mean deviation; n, 
number of eyes; OPP, ocular perfusion pressure; PSD, pattern SD.
J Glaucoma. Author manuscript; available in PMC 2015 February 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Siesky et al. Page 10
TABLE 2
The Ocular Blood Flow Parameters From Color Doppler Imaging are Presented for Each Study Group
AD Mean±SD (n) ED Mean±SD (n) P
OA-PSV (cm/s) 26.51±6.19 (61) 30.90±8.21 (121) 0.0001
OA-EDV (cm/s) 6.92±1.99 (62) 8.17±2.90 (121) 0.0008
OA-RI 0.73±0.056 (63) 0.73±0.070 (138) 0.89
CRA-PSV (cm/s) 7.11±1.87 (62) 8.07±3.12 (121) 0.010
CRA-EDV (cm/s) 1.80±0.70 (65) 1.89±0.77 (139) 0.40
CRA-RI 0.75±0.058 (62) 0.76±0.064 (121) 0.053
TPCA-PSV (cm/s) 5.36±1.35 (48) 6.08±1.35 (95) 0.0037
TPCA-EDV (cm/s) 1.78±0.70 (48) 1.83±0.57 (100) 0.71
TPCA-RI 0.66±0.097 (47) 0.70±0.073 (94) 0.052
NPCA-PSV (cm/s) 5.44±1.37 (47) 6.51±1.46 (99) <0.0001
NPCA-EDV (cm/s) 1.79±0.56 (49) 1.88±0.61 (110) 0.37
NPCA-RI 0.67±0.079 (47) 0.71±0.074 (99) 0.0029
Bold P-values indicate statistical significance.
AD indicates African descent; CRA, central retinal artery; ED, European descent; EDV, end diastolic velocity; NPCA, nasal posterior ciliary 
artery; OA, ophthalmic artery; PSV, peak systolic velocity; RI, Pourcelot vascular resistive index; TPCA, temporal posterior ciliary artery.
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